Equities

Rapid Micro Biosystems Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
RPID:NAQ

Rapid Micro Biosystems Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.91
  • Today's Change0.105 / 2.76%
  • Shares traded158.15k
  • 1 Year change+9.52%
  • Beta1.4174
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

  • Revenue in USD (TTM)30.52m
  • Net income in USD-44.29m
  • Incorporated2006
  • Employees163.00
  • Location
    Rapid Micro Biosystems Inc25 Hartwell AvenueLEXINGTON 02421United StatesUSA
  • Phone+1 (978) 349-3200
  • Fax+1 (302) 636-5401
  • Websitehttps://www.rapidmicrobio.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Citrine Global Corp0.00-1.74m141.93m18.00---------0.0016-0.00160.00-0.00310.00----0.00-118.80-238.43-----------186,483.40---2.10--------25.99------
Anika Therapeutics Inc82.20m13.91m145.08m288.0010.680.98827.181.760.9419-2.285.7010.180.39070.4863.25285,430.606.61-1.877.39-2.0654.2960.7416.92-4.734.47--0.00---0.73270.9077-156.70--24.14--
LENSAR Inc59.14m-51.52m147.40m140.00------2.49-4.39-4.394.99-1.020.89461.7911.51422,435.70-77.94-32.69-121.49-38.9546.1551.51-87.12-54.770.6671------26.8711.87-118.34---40.48--
Nano-X Imaging Ltd12.30m-55.71m148.11m165.00--0.8929--12.04-0.8839-0.88390.1952.400.068313.177.1874,557.58-30.95-28.17-33.30-31.20-98.04---452.82-1,072.253.93--0.0201--13.91--11.95--85.79--
CVRx Inc55.97m-52.02m149.14m206.00--3.10--2.66-2.02-2.022.181.830.46840.74586.49271,694.20-43.53-37.08-47.98-40.0284.4981.33-92.95-151.188.60-8.490.5072--30.5352.31-45.55--66.61--
InfuSystem Holdings Inc141.05m5.52m150.89m502.0028.362.727.961.070.26160.26166.652.731.3810.255.79280,984.105.414.506.565.4655.3555.243.923.861.607.730.2740.007.2210.70168.9211.50-4.62--
Apyx Medical Inc47.90m-14.54m156.67m220.00--24.70--3.27-0.3644-0.36441.190.15460.81131.973.68217,736.40-24.60-27.67-29.90-33.3562.6564.81-30.32-43.613.61-2.040.8507---8.1111.24-25.38---11.11--
Inogen Inc347.03m-25.38m157.19m766.00--0.7972--0.453-1.00-1.0013.477.261.137.929.30453,039.20-8.28-11.40-10.67-13.5044.7644.22-7.31-13.822.75--0.00--6.35-1.4964.97--38.15--
Lucid Diagnostics Inc4.40m-65.84m159.73m72.00------36.31-0.8968-0.89680.05260.19730.116112.2414.9461,097.22-140.60-139.37-301.55-297.39-58.13---1,211.30-2,492.791.88--0.4633--79.00---0.6817------
Acme United Corp194.96m10.02m168.03m633.0018.131.4510.340.86192.432.4347.3530.411.152.036.35307,993.705.927.266.818.5439.5136.345.145.681.758.570.196218.401.566.42-43.6712.7033.594.56
Rapid Micro Biosystems Inc30.52m-44.29m168.65m163.00--3.80--5.53-0.9984-0.99840.68841.000.32091.336.40187,257.70-46.56-38.13-56.14-43.367.72-27.98-145.11-253.022.95--0.3003--24.5711.1810.63---4.24--
Accendra Health Inc6.71bn-410.53m176.35m13.50k------0.0263-5.33-17.4186.97-5.561.477.5915.52496,837.20-9.01-0.3346-17.40-0.524826.1318.20-6.12-0.1460.83861.671.25--3.553.04-778.15--34.30--
Edap Tms SA (ADR)75.72m-23.30m178.35m310.00--6.44--2.36-0.6222-0.62222.020.74030.90812.083.62244,260.50-27.94-11.18-49.24-15.8643.2442.19-30.77-16.630.9729--0.2062--6.117.3810.20--55.92--
Stereotaxis Inc30.07m-24.91m188.52m139.00--29.36--6.27-0.281-0.2810.33930.12660.62321.474.54216,359.70-48.96-31.30-85.25-43.3153.0762.81-78.56-56.040.8108--0.00--0.5491-1.41-14.95--2.89--
Electromed Inc66.22m8.20m192.90m177.0025.084.3520.502.910.92950.92957.505.351.294.042.70374,118.7015.999.3318.9911.0478.0476.5612.388.404.66--0.000.0016.9714.5346.3512.62-20.72--
OraSure Technologies Inc125.70m-60.24m200.85m501.00--0.559--1.60-0.8107-0.81071.695.010.28342.074.91250,904.20-13.08-0.8506-14.16-0.959640.4144.80-46.15-1.396.20--0.0005---54.173.75-136.34---16.43--
Data as of Feb 13 2026. Currency figures normalised to Rapid Micro Biosystems Inc's reporting currency: US Dollar USD

Institutional shareholders

21.25%Per cent of shares held by top holders
HolderShares% Held
Kennedy Lewis Management LPas of 07 Apr 20254.94m12.41%
Parkman Healthcare Partners LLCas of 30 Sep 2025913.44k2.29%
The Vanguard Group, Inc.as of 31 Dec 2025857.44k2.15%
Schonfeld Strategic Advisors LLCas of 30 Sep 2025646.58k1.62%
BlackRock Advisors LLCas of 30 Sep 2025333.06k0.84%
Geode Capital Management LLCas of 30 Sep 2025204.69k0.51%
Evernest Financial Advisors LLCas of 30 Sep 2025200.23k0.50%
BlackRock Fund Advisorsas of 30 Sep 2025144.88k0.36%
Renaissance Technologies LLCas of 30 Sep 2025110.19k0.28%
Vanguard Fiduciary Trust Co.as of 31 Dec 2025109.71k0.28%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.